WYZGA MICHAEL S

CIK 000120125612 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001201256

Recent Transactions

50 trades

Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2026-01-01+110,000→ 0 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2025-06-09+1,500→ 5,555 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (right to buy)
2025-04-17+12,000→ 12,000 total
Award
Tvardi Therapeutics, Inc.$TVRD
Stock Option (right to buy)
2025-04-15+18,441→ 18,441 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2025-02-05+55,000→ 55,000 total
Award
Mereo BioPharma Group plc$MREO
Deferred Restricted Stock Units
2025-02-05+30,487→ 30,487 total
Award
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-17$3.99/sh+25,050→ 25,050 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-06-10+45,000→ 121,667 total
Award
Mereo BioPharma Group plc$MREO
Deferred Restricted Stock Units
2024-02-08+30,783→ 30,783 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2024-02-08+45,000→ 45,000 total
Purchase
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-08-18$1.20/sh+25,000→ 76,667 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-13+45,000→ 51,667 total
Award
Invivyd, Inc.$IVVD
Stock Option (Right to Buy)
2023-05-23+50,000→ 50,000 total
Disposition to Issuer
LogicBio Therapeutics, Inc.
Common Stock
2022-11-16−3,141→ 0 total
Disposition to Issuer
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-11-16−12,500→ 0 total
Award
Invivyd, Inc.$IVVD
Stock Option (Right to Buy)
2022-06-22+75,000→ 75,000 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-06-17+12,500→ 12,500 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-06+6,667→ 6,667 total
Award
Invivyd, Inc.$IVVD
Stock Option (Right to Buy)
2021-08-05+71,186→ 71,186 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2021-06-11+12,500→ 12,500 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2021-06-02$9.50/sh+6,000→ 6,000 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Common Stock
2021-02-26$26.98/sh+10,108→ 21,579 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Stock Option (right to buy)
2021-02-26−10,108→ 0 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2021-02-26$130.11/sh−19,021→ 2,558 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Restricted Stock Units
2021-01-01−3,141→ 0 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Common Stock
2021-01-01+3,141→ 3,141 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2020-07-23+2,558→ 11,471 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2020-06-19+10,000→ 10,000 total
Award
LogicBio Therapeutics, Inc.
Restricted Stock Units
2020-06-19+3,141→ 3,141 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2020-06-10+3,427→ 3,427 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2019-12-19+10,869→ 10,869 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2019-07-31$117.93/sh−5,000→ 8,913 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Common Stock
2019-07-31$26.98/sh+2,500→ 13,913 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Stock Option (right to buy)
2019-07-31−2,500→ 10,108 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2019-07-25+2,801→ 11,413 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-03-13+70,324→ 70,324 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-03-13+6,854→ 6,854 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2019-03-13+70,324→ 70,324 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2019-02-28$96.00/sh−500→ 8,612 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2018-10-18+24,102→ 24,102 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2018-08-28$74.85/sh−2,468→ 9,112 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2018-07-26+606→ 11,580 total
Award
EXACT SCIENCES CORP$EXAS
Deferred Stock Units
2018-07-26+3,230→ 3,230 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2018-06-22+15,000→ 15,000 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2018-06-14+12,500→ 12,500 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2018-05-10$51.53/sh−7,402→ 10,974 total
Award
EXACT SCIENCES CORP$EXAS
Deferred Stock Units
2017-07-27+5,273→ 5,273 total
Award
EXACT SCIENCES CORP$EXAS
Common Stock
2017-07-27+791→ 18,376 total
Award
Akebia Therapeutics, Inc.$AKBA
Stock Option (Right to buy)
2017-06-15+12,500→ 12,500 total
Award
OncoMed Pharmaceuticals Inc
Stock Option (Right to Buy)
2017-06-01+15,000→ 15,000 total

Companies

Recent Filings

Address

500 KENDALL STREET

CAMBRIDGE, MA, 02142

View on SEC.gov